Telix Pharmaceuticals Limited (ASX: TLX)

Telix Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	6,123	3,217	2,258	2,187	972	362
Market Cap Growth	48.77%	42.46%	3.26%	124.90%	168.77%	175.40%
Enterprise Value	5,974	3,112	2,152	2,168	897	319
PE Ratio	922.00	617.41	-21.70	-27.17	-21.67	-12.98
PS Ratio	12.10	6.48	14.11	287.93	186.55	103.82
PB Ratio	40.83	21.61	28.23	1013.48	12.31	5.16
P/FCF Ratio	464.45	245.79	-29.02	-36.05	593.70	-15.20
P/OCF Ratio	136.63	134.71	-35.30	-36.86	496.17	-15.51
EV/Sales Ratio	11.89	6.26	13.45	285.36	172.02	91.64
EV/EBITDA Ratio	102.23	130.90	-31.75	-28.49	-20.21	-8.87
EV/EBIT Ratio	115.97	184.71	-29.41	-26.68	-18.21	-7.93
EV/FCF Ratio	456.37	237.70	-27.66	-35.73	547.46	-13.42
Debt / Equity Ratio	0.12	0.12	0.05	1.18	0.01	0.01
Debt / EBITDA Ratio	0.30	0.73	-0.15	-0.03	-0.05	-0.06
Debt / FCF Ratio	1.33	1.33	-0.13	-0.04	1.35	-0.09
Quick Ratio	1.19	1.19	1.90	1.13	4.62	5.42
Current Ratio	1.43	1.43	2.02	1.25	4.69	5.52
Asset Turnover	1.42	1.25	0.61	0.07	0.03	0.03
Interest Coverage	36.63	1.30	-180.25	-429.88	-41.92	-16.72
Return on Equity (ROE)	3.50%	3.50%	-130.09%	-3730.77%	-56.81%	-39.76%
Return on Assets (ROA)	1.31%	1.31%	-39.94%	-73.32%	-27.30%	-27.16%
Return on Capital (ROIC)	52.27%	17.28%	-80.90%	-1729.76%	-60.64%	-55.75%
Earnings Yield	0.09%	0.16%	-4.61%	-3.68%	-4.62%	-7.70%
FCF Yield	0.22%	0.41%	-3.45%	-2.77%	0.17%	-6.58%
Buyback Yield / Dilution	-14.39%	-4.21%	-10.08%	-9.69%	-10.21%	-15.49%
Total Shareholder Return	-14.39%	-4.21%	-10.08%	-9.69%	-10.21%	-15.49%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.